Form 8-K/A - Current report: [Amend]
SEC Accession No. 0000950135-08-006444
Filing Date
2008-10-10
Accepted
2008-10-10 11:59:03
Documents
9
Period of Report
2008-10-01
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 OXIGENE, INC. b72517kae8vkza.htm 8-K/A 17627
2 EX-4.1 FORM OF DIRECT INVESTMENT WARRANT, TO BE DATED AS OF OCTOBER 17, 2008 b72517kaexv4w1.htm EX-4.1 83286
3 EX-10.1 TECHNOLOGY LICENSE AGREEMENT DATED AS OF OCTOBER 1, 2008 b72517kaexv10w1.htm EX-10.1 187315
4 EX-10.2 NOVATED AND RESTATED TECHNOLOGY LICENSE AGREEMENT b72517kaexv10w2.htm EX-10.2 205561
5 EX-10.3 STOCK AND WARRANT PURCHASE AGREEMENT DATED AS OF OCTOBER 1, 2008 b72517kaexv10w3.htm EX-10.3 515719
6 EX-10.4 PURCHASE OPTION AGREEMENT DATED AS OF OCTOBER 1, 2008 b72517kaexv10w4.htm EX-10.4 200014
7 EX-10.5 REGISTRATION RIGHTS AGREEMENT DATED AS OF OCTOBER 1, 2008 b72517kaexv10w5.htm EX-10.5 136336
8 EX-10.6 ADDITIONAL FUNDING AGREEMENT DATED AS OF OCTOBER 1, 2008 b72517kaexv10w6.htm EX-10.6 43151
9 EX-10.7 AMENDMENT NO. 1 TO THE STOCKHOLDER RIGHTS AGREEMENT b72517kaexv10w7.htm EX-10.7 9403
  Complete submission text file 0000950135-08-006444.txt   1399759
Mailing Address
Business Address 321 ARSENAL STREET WATERTOWN MA 02472 6176737800
OXIGENE INC (Filer) CIK: 0000908259 (see all company filings)

IRS No.: 133679168 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 000-21990 | Film No.: 081117627
SIC: 2836 Biological Products, (No Diagnostic Substances)